BACKGROUND: Lung transplantation has become an effective therapeutic option for selected patients with end stage lung disease. Long-term survival is limited by chronic rejection manifest as bronchiolitis obliterans syndrome (BOS). The aspiration of gastric contents has been implicated as a causative or additive factor leading to BOS. Gastroesophageal reflux (GER) and altered foregut motility are common both before and after lung transplantation. Further, the normal defense mechanisms against reflux are impaired in the allograft. Recent studies using biomarkers of aspiration have added to previous association studies to provide a growing body of evidence supporting the link between rejection and GER. Further, the addition of high-resolution manometry (HRM) and impedance technology to characterize bolus transit and the presence and extent of reflux regardless of pH might better identify at-risk patients. Although additional prospective studies are needed, fundoplication appears useful in the prevention or treatment of post-transplant BOS. PURPOSE: This review will highlight the existing literature on the relationship of gastroesophageal reflux and altered motility to lung transplant rejection, particularly BOS. The article will conclude with a discussion of the evaluation and management of patients undergoing lung transplantation at our center.
BACKGROUND: Lung transplantation has become an effective therapeutic option for selected patients with end stage lung disease. Long-term survival is limited by chronic rejection manifest as bronchiolitis obliterans syndrome (BOS). The aspiration of gastric contents has been implicated as a causative or additive factor leading to BOS. Gastroesophageal reflux (GER) and altered foregut motility are common both before and after lung transplantation. Further, the normal defense mechanisms against reflux are impaired in the allograft. Recent studies using biomarkers of aspiration have added to previous association studies to provide a growing body of evidence supporting the link between rejection and GER. Further, the addition of high-resolution manometry (HRM) and impedance technology to characterize bolus transit and the presence and extent of reflux regardless of pH might better identify at-risk patients. Although additional prospective studies are needed, fundoplication appears useful in the prevention or treatment of post-transplant BOS. PURPOSE: This review will highlight the existing literature on the relationship of gastroesophageal reflux and altered motility to lung transplant rejection, particularly BOS. The article will conclude with a discussion of the evaluation and management of patients undergoing lung transplantation at our center.
Authors: C L Lau; S M Palmer; D N Howell; R McMahon; D Hadjiliadis; J Gaca; T N Pappas; R D Davis; S Eubanks Journal: Surg Endosc Date: 2002-07-29 Impact factor: 4.584
Authors: Sudeep S Sodhi; Jin-Ping Guo; Alan H Maurer; Gerald O'Brien; Radhika Srinivasan; Henry P Parkman Journal: J Clin Gastroenterol Date: 2002-01 Impact factor: 3.062
Authors: Savio C Reddymasu; Shailender Singh; Rajakumar Sankula; Teri A H Lavenbarg; Mojtaba Olyaee; Richard W McCallum Journal: Am J Med Sci Date: 2009-03 Impact factor: 2.378
Authors: V Mertens; K Blondeau; A Pauwels; R Farre; B Vanaudenaerde; R Vos; G Verleden; D E Van Raemdonck; L J Dupont; D Sifrim Journal: Dig Dis Sci Date: 2009-02-25 Impact factor: 3.199
Authors: Jordan Burlen; Suma Chennubhotla; Shifat Ahmed; Sarah Landes; Allan Ramirez; Abigail M Stocker; Thomas L Abell Journal: Gastroenterology Res Date: 2022-06-22
Authors: F L Kelly; V E Kennedy; R Jain; N S Sindhwani; C A Finlen Copeland; L D Snyder; J P Eu; E B Meltzer; B L Brockway; E Pavlisko; B R Stripp; S M Palmer Journal: Am J Transplant Date: 2012-08-06 Impact factor: 8.086